Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association.

OBJECTIVE To establish, in a single resource, up-to-date recommendations for primary care physicians regarding prevention strategies for a first stroke. PARTICIPANTS Members of the National Stroke Association's (NSA's) Stroke Prevention Advisory Board and Cedars-Sinai Health System Department of Health Services Research convened on April 9, 1998, in an open meeting. The conference attendees, selected to participate by the NSA, were recognized experts in neurology (9), cardiology (2), family practice (1), nursing (1), physician assistant practices (1), and health services research (2). EVIDENCE A literature review was carried out by the Department of Health Services Research, Cedars-Sinai Health System, Los Angeles, Calif, using the MEDLINE database search for 1990 through April 1998 and updated in November 1998. English-language guidelines, statements, meta-analyses, and overviews on prevention of a first stroke were reviewed. CONSENSUS PROCESS At the meeting, members of the advisory board identified 6 important stroke risk factors (hypertension, myocardial infarction [MI], atrial fibrillation, diabetes mellitus, blood lipids, asymptomatic carotid artery stenosis), and 4 lifestyle factors (cigarette smoking, alcohol use, physical activity, diet). CONCLUSIONS Several interventions that modify well-documented and treatable cardiovascular and cerebrovascular risk factors can reduce the risk of a first stroke. Good evidence for direct stroke reduction exists for hypertension treatment; using warfarin for patients after MI who have atrial fibrillation, decreased left ventricular ejection fraction, or left ventricular thrombus; using 3-hydroxy-3 methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors for patients after MI; using warfarin for patients with atrial fibrillation and specific risk factors; and performing carotid endarterectomy for patients with stenosis of at least 60%. Observational studies support the role of modifying lifestyle-related risk factors (eg, smoking, alcohol use, physical activity, diet) in stroke prevention. Measures to help patients improve adherence are an important component of a stroke prevention plan.

[1]  R. Sacco,et al.  Cigarette smoking as a determinant of high-grade carotid artery stenosis in Hispanic, black, and white patients with stroke or transient ischemic attack. , 1998, Stroke.

[2]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[3]  K. Patrick,et al.  Physical Activity and Public Health: A Recommendation From the Centers for Disease Control and Prevention and the American College of Sports Medicine , 1995 .

[4]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[5]  R B D'Agostino,et al.  Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. , 1994, Stroke.

[6]  W. Willett,et al.  Cigarette smoking and risk of stroke in middle-aged women. , 1988, The New England journal of medicine.

[7]  D. Singer,et al.  Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care. , 1998, The American journal of cardiology.

[8]  N. Wheeldon,et al.  Screening for atrial fibrillation in primary care , 1998, Heart.

[9]  P. Williams,et al.  High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. , 1996, The New England journal of medicine.

[10]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[11]  T. Lakka,et al.  Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. , 1993, Journal of clinical epidemiology.

[12]  R B Haynes,et al.  An overview of interventions to improve compliance with appointment keeping for medical services. , 1992, JAMA.

[13]  R. Lorenz.  The problem with intensive therapy. , 1998, Diabetes care.

[14]  P. Gorelick.  The status of alcohol as a risk factor for stroke. , 1989, Stroke.

[15]  P Smith,et al.  The effect of warfarin on mortality and reinfarction after myocardial infarction. , 1990, The New England journal of medicine.

[16]  G. Samsa,et al.  Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. , 1995, Archives of internal medicine.

[17]  P. Wolf.  Cigarettes, alcohol, and stroke. , 1986, The New England journal of medicine.

[18]  Strandness De.  Angiography Before Carotid Endarterectomy—No , 1995 .

[19]  R B D'Agostino,et al.  Cigarette smoking as a risk factor for stroke. The Framingham Study. , 1988, JAMA.

[20]  N. Bornstein,et al.  Vascular Risks of Asymptomatic Carotid Stenosis , 1991, Stroke.

[21]  P. Rudd.  Clinicians and patients with hypertension: unsettled issues about compliance. , 1995, American heart journal.

[22]  P. Wolf,et al.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke , 1978, Neurology.

[23]  J. Broderick,et al.  The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. , 1998, Stroke.

[24]  C. Elliott.  Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota: Davis PH, Dambrosia JM, Schoenberg BS, et al Ann Neurol 22: 319–327 Sep 1987 , 1988 .

[25]  J. Cairns,et al.  Antithrombotic agents in coronary artery disease. , 1989, Chest.

[26]  L. Chambless,et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.

[27]  R. Spasoff.  Healing Medicare: Managing Health System Change the Canadian Way , 1995 .

[28]  E. Roccella,et al.  Hypertension-related morbidity and mortality in the southeastern United States. , 1997, The American journal of the medical sciences.

[29]  G. Lamas,et al.  Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.

[30]  G. Ferguson,et al.  Guidelines for the use of carotid endarterectomy: current recommendations from the Canadian Neurosurgical Society. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[31]  J. Dolovich,et al.  The need for extended treatment of anaphylaxis. , 1980, Canadian Medical Association journal.

[32]  P. Duncan,et al.  Primary Stroke Prevention in Nonvalvular Atrial Fibrillation: Implementing the Clinical Trial Findings , 1997, The Annals of pharmacotherapy.

[33]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997, JAMA.

[34]  N. Santanello,et al.  Cholesterol reduction yields clinical benefit. A new look at old data. , 1995, Circulation.

[35]  R. Sacco,et al.  Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. , 1997, Stroke.

[36]  J. Manson,et al.  Physical activity and incidence of non-insulin-dependent diabetes mellitus in women , 1991, The Lancet.

[37]  Daniel B Hier,et al.  Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke , 1989, Neurology.

[38]  R. D'Agostino,et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. , 1995, The New England journal of medicine.

[39]  W M O'Fallon,et al.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. , 1996, Stroke.

[40]  Richard A. Kronmal,et al.  Distribution and Correlates of Sonographically Detected Carotid Artery Disease in the Cardiovascular Health Study , 1992, Stroke.

[41]  V. Fuster,et al.  Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. , 1996, Circulation.

[42]  K. Heaton,et al.  MODERATE ALCOHOL INTAKE REDUCES BILE CHOLESTEROL SATURATION AND RAISES HDL CHOLESTEROL , 1983, The Lancet.

[43]  J. Dambrosia,et al.  Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota , 1987, Annals of neurology.

[44]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[45]  P. Ueland,et al.  Plasma Homocysteine and Cardiovascular Disease , 2000 .

[46]  A. Davies,et al.  Endarterectomy for asymptomatic carotid artery stenosis , 1995, BMJ.

[47]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[48]  N. Delanty,et al.  Vascular effects of statins in stroke. , 1997, Stroke.

[49]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997 .

[50]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[51]  P. Wolf,et al.  Protective effect of fruits and vegetables on development of stroke in men. , 1995, JAMA.

[52]  G. Howard,et al.  Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. , 1998, JAMA.

[53]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[54]  D. Reda,et al.  Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. , 1995, The New England journal of medicine.

[55]  R. Beaglehole,et al.  Cigarette smoking and risk of premature stroke in men and women. , 1986, British medical journal.

[56]  U. P. S. T. Force.  Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force , 1996 .

[57]  E. Devine,et al.  A Meta‐Analysis of the Effects Of Psychoeducational Care in Adults with Hypertension , 1995, Nursing research.

[58]  J. Hedner,et al.  Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. , 1995, Sleep.

[59]  S. Mcphee,et al.  Current Medical Diagnosis & Treatment , 1993 .

[60]  J. Toole,et al.  Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. , 1998, Circulation.

[61]  S. Woolf,et al.  Practice guidelines: a new reality in medicine. I. Recent developments. , 1990, Archives of internal medicine.

[62]  Exercise in the prevention of stroke. , 1994 .

[63]  U. Goldbourt,et al.  Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review , 1998 .

[64]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[65]  H. Chen,et al.  Effects of exercise training and deconditioning on platelet function in men. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[66]  R. Westendorp,et al.  Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. , 1997, Stroke.

[67]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[68]  P. Hebert.  Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. , 1997 .

[69]  D. Reed,et al.  Risk of stroke in male cigarette smokers. , 1986, The New England journal of medicine.

[70]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[71]  P. Gorelick,et al.  Stroke Prevention: An Opportunity for Efficient Utilization of Health Care Resources During the Coming Decade , 1994, Stroke.

[72]  K. A. McKibbon,et al.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications , 1996, The Lancet.

[73]  P. Amarenco,et al.  Antithrombotic and thrombolytic therapy for ischemic stroke. , 1998, Chest.

[74]  S. Oparil,et al.  Physical activity and cardiovascular health , 1996 .

[75]  Steven N. Blair,et al.  Influences of Cardiorespiratory Fitness and Other Precursors on Cardiovascular Disease and All-Cause Mortality in Men and Women , 1996 .

[76]  D. Sackett,et al.  Rules of evidence and clinical recommendations on the use of antithrombotic agents. , 1989, Chest.

[77]  B. Hsi,et al.  Estimating a patient's cooperation with his regimen , 1971, The American journal of the medical sciences.

[78]  P. Gorelick,et al.  Status of lipids as a risk factor for stroke. , 1997, Neuroepidemiology.

[79]  P D Mullen,et al.  A meta-analysis of trials evaluating patient education and counseling for three groups of preventive health behaviors. , 1997, Patient education and counseling.

[80]  J. Holmes,et al.  Lifetime cost of stroke in the United States. , 1996, Stroke.

[81]  J. Avorn,et al.  Physician Attitudes Concerning Warfarin for Stroke Prevention in Atrial Fibrillation: Results of a Survey of Long‐Term Care Practitioners , 1997, Journal of the American Geriatrics Society.

[82]  P. Koudstaal.  Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. , 1995, The New England journal of medicine.

[83]  N. Pellegrini,et al.  Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. , 1996, European journal of clinical nutrition.

[84]  G. Guyatt,et al.  Effect of HMGcoA Reductase Inhibitors on Stroke , 1998, Annals of Internal Medicine.

[85]  E. Barrett-Connor,et al.  Dietary potassium and stroke-associated mortality. A 12-year prospective population study. , 1987, The New England journal of medicine.

[86]  B Rosner,et al.  Smoking cessation and decreased risk of stroke in women. , 1993, JAMA.

[87]  J. Szalai,et al.  Consensus against both endarterectomy and routine screening for asymptomatic carotid artery stenosis. Canadian Stroke Consortium. , 1997, Archives of neurology.

[88]  P. Gorelick,et al.  Plasma Lipids and Stroke , 1999, Journal of cardiovascular risk.

[89]  M. Hill,et al.  The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. , 1997, Circulation.

[90]  D. Beevers,et al.  Stroke and alcohol consumption. , 1986, The New England journal of medicine.

[91]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[92]  J. Cairns,et al.  Prevention of stroke in patients with nonvalvular atrial fibrillation , 1998, Neurology.

[93]  R. Rosenson,et al.  Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. , 1998, JAMA.

[94]  J. Mason,et al.  North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care , 1998 .

[95]  D. Reed,et al.  Alcohol and hemorrhagic stroke. The Honolulu Heart Program. , 1986, JAMA.

[96]  W H Baker,et al.  An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance). A multicenter experience. Asymptomatic Carotid Atherosclerosis Study Investigators. , 1996, Stroke.

[97]  D. Tanné,et al.  Frequency and Prognosis of Stroke/TIA Among 4808 Survivors of Acute Myocardial Infarction , 1993, Stroke.

[98]  C. Hennekens,et al.  Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. , 1997, JAMA.

[99]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[100]  M. Eliasziw,et al.  The identification by imaging methods of patients who might benefit from carotid endarterectomy. , 1995, Archives of Neurology.

[101]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[102]  M Marmot,et al.  INTERSALT Study Findings Public Health and Medical Care Implications , 1989, Hypertension.

[103]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[104]  G. Beevers,et al.  Meta-analysis of relation between cigarette smoking and stroke. , 1989, BMJ.

[105]  Cathy M. Helgason,et al.  American Heart Association Prevention Conference IV: Prevention and Rehabilitation of Stroke Introduction , 1997 .

[106]  D B Matchar,et al.  Medical Treatment for Stroke Prevention , 1994, Annals of Internal Medicine.